{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:56:19Z","timestamp":1792828579282,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":1685,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1038\/s41379-018-0016-8","type":"journal-article","created":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T14:44:37Z","timestamp":1518446677000},"page":"900-909","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":162,"title":["Epidemiology and biomarker profile of pituitary adenohypophysial tumors"],"prefix":"10.1016","volume":"31","author":[{"given":"Ozgur","family":"Mete","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Cintosun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irwin","family":"Pressman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia L.","family":"Asa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-018-0016-8_bib1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/oxfordjournals.epirev.a036232","article-title":"Epidemiology of pituitary adenomas","volume":"3","author":"Gold","year":"1981","journal-title":"Epid Rev"},{"key":"10.1038\/s41379-018-0016-8_bib2","first-page":"317","article-title":"Surgical pathology of the pituitary: the adenomas","volume":"19","author":"Scheithauer","year":"1984","journal-title":"Part I Pathol Annu"},{"key":"10.1038\/s41379-018-0016-8_bib3","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/cncr.20412","article-title":"The prevalence of pituitary adenomas: a systematic review","volume":"101","author":"Ezzat","year":"2004","journal-title":"Cancer"},{"key":"10.1038\/s41379-018-0016-8_bib4","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1210\/jc.2006-1668","article-title":"High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium","volume":"91","author":"Daly","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-018-0016-8_bib5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","article-title":"Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)","volume":"72","author":"Fernandez","year":"2010","journal-title":"Clin Endocrinol"},{"key":"10.1038\/s41379-018-0016-8_bib6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1530\/EJE-14-0144","article-title":"The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011","volume":"171","author":"Tjornstrand","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1038\/s41379-018-0016-8_bib7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1530\/EJE-15-0189","article-title":"The epidemiology of pituitary adenomas in Iceland, 1955-2012: a nationwide population-based study","volume":"173","author":"Agustsson","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1038\/s41379-018-0016-8_bib8","first-page":"2172","article-title":"[Epidemiology of pituitary adenoma: results of the first Swiss study]","volume":"5","author":"Fontana","year":"2009","journal-title":"Rev Med Suisse"},{"key":"10.1038\/s41379-018-0016-8_bib9","doi-asserted-by":"crossref","first-page":"C5","DOI":"10.1530\/ERC-17-0004","article-title":"From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal","volume":"24","author":"Asa","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1038\/s41379-018-0016-8_bib10","series-title":"Tumors of the pituitary gland. AFIP Atlas of Tumor Pathology, Series 4, Fascicle 15","first-page":"55","article-title":"Pituitary adenomas","author":"Asa","year":"2011"},{"key":"10.1038\/s41379-018-0016-8_bib11","doi-asserted-by":"crossref","first-page":"640","DOI":"10.5858\/2010-0470-SAR1.1","article-title":"Protocol for the examination of specimens from patients with primary pituitary tumors","volume":"135","author":"Nose","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/s41379-018-0016-8_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/modpathol.2015.151","article-title":"Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas","volume":"29","author":"Mete","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-018-0016-8_bib13","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1530\/eje.0.1400250","article-title":"Reduced expression levels of the cell-cycle inhibitor p27Kip1 in human pituitary adenomas","volume":"140","author":"Bamberger","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"10.1038\/s41379-018-0016-8_bib14","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1210\/jcem.87.6.8517","article-title":"Expression of phosphorylatedp27(Kip1) protein and Jun activation domain-binding protein 1 in human pituitary tumors","volume":"87","author":"Korbonits","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-018-0016-8_bib15","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1210\/jcem.84.10.6066","article-title":"Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors","volume":"84","author":"Lidhar","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-018-0016-8_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/sj.onc.1201516","article-title":"Mutation and expression analysis of the p27\/kip1 gene in corticotrophin- secreting tumours","volume":"16","author":"Dahia","year":"1998","journal-title":"Oncogene"},{"key":"10.1038\/s41379-018-0016-8_bib17","series-title":"Pathology and genetics of tumours of endocrine organs.","first-page":"10","article-title":"Pituitary Tumors: Introduction","author":"Lloyd","year":"2004"},{"key":"10.1038\/s41379-018-0016-8_bib18","series-title":"Endocrine pathology","first-page":"315","article-title":"The Pituitary Gland","author":"Asa","year":"2016"},{"key":"10.1038\/s41379-018-0016-8_bib19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12022-015-9398-z","article-title":"The complementary role of transcription factors in the accurate diagnosis of clinically nonfunctioning pituitary adenomas","volume":"26","author":"Nishioka","year":"2015","journal-title":"Endocr Pathol"},{"key":"10.1038\/s41379-018-0016-8_bib20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF00430697","article-title":"Null cell adenoma of the human pituitary","volume":"387","author":"Kovacs","year":"1980","journal-title":"Virchows Arch"},{"key":"10.1038\/s41379-018-0016-8_bib21","series-title":"Endocrine pathology update","first-page":"17","article-title":"Null cell adenomas of the pituitary: attempts to resolve their cytogenesis","author":"Kovacs","year":"1990"},{"key":"10.1038\/s41379-018-0016-8_bib22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF00783026","article-title":"Oncocytomas and null cell adenomas of the human pituitary: morphometric and in vitro functional comparison","volume":"413","author":"Yamada","year":"1988","journal-title":"Virchows Arch"},{"key":"10.1038\/s41379-018-0016-8_bib23","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1210\/jcem-62-5-1011","article-title":"Gonadotropin secretion in vitro by human pituitary null cell adenomas and oncocytomas","volume":"62","author":"Asa","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-018-0016-8_bib24","first-page":"2165","article-title":"The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph","volume":"81","author":"Asa","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-018-0016-8_bib25","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1530\/ERC-16-0496","article-title":"Pituitary acromegaly: not one disease","volume":"24","author":"Asa","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1038\/s41379-018-0016-8_bib26","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1148\/radiol.2282020695","article-title":"Comparison of growth hormone-producing and non-growth hormone-producing pituitary adenomas: imaging characteristics and pathologic correlation","volume":"228","author":"Hagiwara","year":"2003","journal-title":"Radiology"},{"key":"10.1038\/s41379-018-0016-8_bib27","series-title":"Endocrine pathology.","first-page":"109","article-title":"Radiological imaging","author":"Bakir","year":"2016"},{"key":"10.1038\/s41379-018-0016-8_bib28","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1530\/ERC-16-0356","article-title":"T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly","volume":"23","author":"Potorac","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"10.1038\/s41379-018-0016-8_bib29","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1530\/eje.0.1330686","article-title":"In vivo responsiveness of morphological variants of growth hormone-producing pituitary adenomas to octreotide","volume":"133","author":"Ezzat","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"10.1038\/s41379-018-0016-8_bib30","series-title":"Tumors of the pituitary gland. Atlas of Tumor Pathology","first-page":"47","article-title":"Pituitary adenomas","author":"Asa","year":"1998"},{"key":"10.1038\/s41379-018-0016-8_bib31","first-page":"798","article-title":"The cytogenesis and pathogenesis of pituitary adenomas","volume":"19","author":"Asa","year":"1998","journal-title":"Endocr Rev"},{"key":"10.1038\/s41379-018-0016-8_bib32","doi-asserted-by":"crossref","first-page":"6290","DOI":"10.1210\/jc.2005-0998","article-title":"The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegaly","volume":"90","author":"Bhayana","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-018-0016-8_bib33","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1365-2265.2011.04163.x","article-title":"Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly","volume":"76","author":"Fougner","year":"2012","journal-title":"Clin Endocrinol"},{"key":"10.1038\/s41379-018-0016-8_bib34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2265.2011.04286.x","article-title":"Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly","volume":"77","author":"Heck","year":"2012","journal-title":"Clin Endocrinol"},{"key":"10.1038\/s41379-018-0016-8_bib35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1507\/endocrj.EJ11-0177","article-title":"Differential expression of genes related to drug responsiveness between sparsely and densely granulated somatotroph adenomas","volume":"59","author":"Kato","year":"2012","journal-title":"Endocr J"},{"key":"10.1038\/s41379-018-0016-8_bib36","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s11102-012-0445-1","article-title":"Growth hormone granulation pattern and somatostatin receptor subtype 2A correlate with postoperative somatostatin receptor ligand response in acromegaly: a large single center experience","volume":"16","author":"Brzana","year":"2013","journal-title":"Pituitary"},{"key":"10.1038\/s41379-018-0016-8_bib37","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1530\/EJE-12-0864","article-title":"Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naive patients with somatotroph adenomas","volume":"168","author":"Larkin","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1038\/s41379-018-0016-8_bib38","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12020-014-0383-y","article-title":"Growth hormone tumor histological subtypes predict response to surgical and medical therapy","volume":"49","author":"Kiseljak-Vassiliades","year":"2015","journal-title":"Endocrine"},{"key":"10.1038\/s41379-018-0016-8_bib39","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12022-008-9029-z","article-title":"Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form","volume":"19","author":"Obari","year":"2008","journal-title":"Endocr Pathol"},{"key":"10.1038\/s41379-018-0016-8_bib40","series-title":"WHO Classification of Tumours of Endocrine Organs","first-page":"14","article-title":"Pituitary adenoma","author":"Osamura","year":"2017"},{"key":"10.1038\/s41379-018-0016-8_bib41","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s12022-017-9498-z","article-title":"Overview of the 2017 WHO classification of pituitary tumors","volume":"28","author":"Mete","year":"2017","journal-title":"Endocr Pathol"},{"key":"10.1038\/s41379-018-0016-8_bib42","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1750-3639.2012.00599.x","article-title":"Clinicopathological correlations in pituitary adenomas","volume":"22","author":"Mete","year":"2012","journal-title":"Brain Pathol"},{"key":"10.1038\/s41379-018-0016-8_bib43","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12022-013-9270-y","article-title":"The role of mediators of cell invasiveness, motility, and migration in the pathogenesis of silent corticotroph adenomas","volume":"24","author":"Mete","year":"2013","journal-title":"Endocr Pathol"},{"key":"10.1038\/s41379-018-0016-8_bib44","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00701-012-1378-1","article-title":"Clinical features of silent corticotroph adenomas","volume":"154","author":"Alahmadi","year":"2012","journal-title":"Acta Neurochir"},{"key":"10.1038\/s41379-018-0016-8_bib45","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.humpath.2004.04.016","article-title":"Silent corticotroph adenomas: further clinical and pathological observations","volume":"35","author":"Lopez","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-018-0016-8_bib46","first-page":"723","article-title":"Clinically silent corticotroph tumors of the pituitary gland","volume":"47","author":"Scheithauer","year":"2000","journal-title":"Neurosurgery"},{"key":"10.1038\/s41379-018-0016-8_bib47","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF01600224","article-title":"In situ hybridization study of pro-opiomelanocortin (POMC) gene expression in human pituitary corticotrophs and their adenomas","volume":"419","author":"Stefaneanu","year":"1991","journal-title":"Virchows Arch"},{"key":"10.1038\/s41379-018-0016-8_bib48","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/0002-9343(78)90236-X","article-title":"Silent corticotroph cell adenoma with lysosomal accumulation and crinophagy. A distinct clinicopathologic entity","volume":"64","author":"Kovacs","year":"1978","journal-title":"Am J Med"},{"key":"10.1038\/s41379-018-0016-8_bib49","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/PAS.0000000000000784","article-title":"Pituitary adenomas presenting as sinonasal or nasopharyngeal masses: a case series illustrating potential diagnostic pitfalls","volume":"41","author":"Hyrcza","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-018-0016-8_bib50","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1750-3639.2002.tb00458.x","article-title":"Vitamin D and its analog EB1089 induce p27 accumulation and diminish association of p27 with Skp2 independent of PTEN in pituitary corticotroph cells","volume":"12","author":"Liu","year":"2002","journal-title":"Brain Pathol"},{"key":"10.1038\/s41379-018-0016-8_bib51","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.beem.2010.01.001","article-title":"MEN-4 and other multiple endocrine neoplasias due to cyclin-dependent kinase inhibitors (p27(Kip1) and p18(INK4C)) mutations","volume":"24","author":"Georgitsi","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1038\/s41379-018-0016-8_bib52","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1210\/jc.2006-2843","article-title":"Germline CDKN1B\/p27Kip1 mutation in multiple endocrine neoplasia","volume":"92","author":"Georgitsi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-018-0016-8_bib53","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2013.08.002","article-title":"Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)","volume":"386","author":"Thakker","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1038\/s41379-018-0016-8_bib54","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1210\/jc.2003-031489","article-title":"Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: relation to tumor type, size, proliferation, and invasiveness","volume":"89","author":"Qian","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-018-0016-8_bib55","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.pathol.4.110807.092259","article-title":"The pathogenesis of pituitary tumors","volume":"4","author":"Asa","year":"2009","journal-title":"Annu Rev Pathol"},{"key":"10.1038\/s41379-018-0016-8_bib56","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1210\/me.2013-1412","article-title":"FGFR4 polymorphic variants modulate phenotypic features of Cushing disease","volume":"28","author":"Nakano-Tateno","year":"2014","journal-title":"Mol Endocrinol"},{"key":"10.1038\/s41379-018-0016-8_bib57","doi-asserted-by":"crossref","first-page":"e1002400","DOI":"10.1371\/journal.pgen.1002400","article-title":"The FGFR4-G388R polymorphism promotes mitochondrial STAT3 serine phosphorylation to facilitate pituitary growth hormone cell tumorigenesis","volume":"7","author":"Tateno","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1038\/s41379-018-0016-8_bib58","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1586\/17446651.2016.1153422","article-title":"Aggressive pituitary tumors or localized pituitary carcinomas: defining pituitary tumors","volume":"11","author":"Asa","year":"2016","journal-title":"Exp. Rev. Endocrinol. Metab"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41379-018-0016-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-018-0016-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222014910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222014910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-018-0016-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:49:58Z","timestamp":1760230198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222014910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0893395222014910"],"URL":"https:\/\/doi.org\/10.1038\/s41379-018-0016-8","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology and biomarker profile of pituitary adenohypophysial tumors","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-018-0016-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}